Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
130 Results Found
FDA recommends strategies to conserve prefilled saline flush syringes
The Food and Drug Administration today recommended strategies for health care providers to conserve prefilled 0.9% sodium chloride intravenous lock/flush syringes.
Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024
Pending federal approval, Civica Rx, the nonprofit consortium of U.S. hospitals, plans to manufacture and distribute several generic insulins, continuing its mission to alleviate chronic shortages of inpatient drugs and reduce drug prices.
Report calls for federal, other action to prevent medical supply shortages
A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine recommends actions to help prevent medical product shortages and ensure access to essential drugs and devices.
Emergency Physicians Sue Anthem in Georgia Over ED Policy
The American College of Emergency Physicians and Medical Association of Georgia this week filed a federal lawsuit seeking to compel Anthem's Blue Cross Blue Shield of Georgia to rescind a policy that retroactively denies coverage for emergency patients.
Intermountain Sells GPO as It Sharpens Focus
Intermountain Healthcare has agreed to sell its Intalere group purchasing organization (formerly Amerinet) to Vizient, a GPO that also provides data analytics and performance-improvement insights to health systems.
AHA, Others Comment to DEA on Controlled Substances Quotas
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
Drug Safety Summit Examined National Security Implications of Global Drug Manufacturing
Leading healthcare groups convened a summit, “Safe, Effective, and Accessible High-Quality Medicines as a Matter of National Security,” on July 27-31 to examine the resilience of the U.S. pharmaceutical supply chain in light of the current state of global pharmaceutical manufacturing.
AHA, others urge DEA to increase annual caps for controlled substances
The AHA, American Medical Association, American Society of Anesthesiologists, American Society of Health-System Pharmacists, and Association for Clinical Oncology are urging the Drug Enforcement Agency to allow drug manufacturers and 503B outsourcing facilities to receive increased annual production quota controlled-substance allocations during the COVID-19 crisis.
AHA, others voice support for drug shortages bill
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D-Ore., and Gus Bilirakis, D-Fla., introduced the Preventing Drug Shortages Act (H.R. 6080).
AHA, Health Organizations Express Support for S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act
AHA, health organizations letter to Senate Chairman, Lamar Alexander and Ranking Member Patty Murray, expressing support of S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act.